Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 August 2022 | Story Leonie Bolleurs | Photo Francois van Vuuren, iFlair Photography
UFS Sasol Solar car
Team UFS, which has entered its solar-powered vehicle, Lengau (meaning Cheetah in Sesotho), will compete against more than 11 other teams, both local and international. Pictured here is the entire team during one of the road tests at Brandkop in Bloemfontein.

It is almost three years after Team UFS first decided to put a solar-powered vehicle on the road. Within a few days, this dream of participating in the international Sasol Solar Challenge will become a reality when they depart from Carnival City in Johannesburg on 9 September 2022.

For the challenge, the team of ten members will stop at six points between the departure point and the V&A Waterfront in Cape Town, where they will arrive on 16 September 2022.

Completing the estimated distance of 2 500 km

“The team that finishes with the greatest distance covered within the allotted time, will win the challenge,” says Dr Hendrik van Heerden from the UFS Department of Physics and project manager of Team UFS. 

The UFS, which has entered its solar-powered vehicle, Lengau (meaning Cheetah in Sesotho), will compete against more than 11 other teams, both local and international.

Dr Van Heerden’s two main objectives in entering the challenge, are to build a solar-powered vehicle robust enough to complete the estimated distance of 2 500 km during the 2022 Sasol Solar Challenge. Furthermore, he aims to establish capacity in the students and staff through acquired practical knowledge on the management, design, construction, and actual racing of solar-powered vehicles, which is to form the basis for participation in future projects and event competitions. 

Bringing together expertise from the UFS Departments of Physics, Engineering Sciences, Computer Sciences and Informatics, Electronics and Instrumentation, and Geography, the team of 23 started with the construction of their vehicle on 18 October 2021. 

Just over 10 months later and the car is fully functional, already passed a few road tests, and the crew is ready for the big challenge ahead.

The three drivers, Albert Dreyer, Monica van der Walt, Denver de Koker, together with back-up driver Lukas Erasmus, will travel on public roads via a predefined route over eight days, driving every day between 07:30 and 17:00. The aluminium-frame vehicle will weigh up to 370 kg, including the frame, the five solar panels, and the driver, and can reach a maximum speed of 60 km per hour (they aim to average 45 km/hour). 

According to the Sasol Solar Challenge rules and regulations, no driver is allowed to drive for longer than two hours. The capacity of the batteries and the availability of sun will determine how often the drivers will need to stop to recharge the solar batteries. 

Popularising electric vehicle technologies

This is the first time that Team UFS will be participating in the Sasol Solar Challenge. A guardedly optimistic Dr Van Heerden says their goal is to complete the full distance without breakages, and to accumulate as much knowledge and information as possible. With the next Sasol Solar Challenge in two years’ time, they plan to enter again. 

“Our long-term aim is to continually improve on the design, technology, science, and project implementation to participate in events and challenges around ‘green’ energy and relevant technologies. An additional aim is the popularisation of electric vehicle (EV) technologies through outreach programmes,” says Dr Van Heerden. 

Prof Koos Terblans, Head of the Department of Physics, says one of the key benefits of this project was that the group, consisting of personnel and students from different departments, learned to work together as one team. “Together, they worked and made plans to collect and apply the maximum amount of energy. Looking at the bigger picture, they are solving a worldwide problem, that of harvesting and applying energy. I am very excited that they have come this far; this is a first for the university.”

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept